key: cord-0956397-54258ex7 authors: Wilcox, M. Elizabeth; Shankar-Hari, Manu; McAuley, Daniel F. title: Delirium in COVID-19: can we make the unknowns knowns? date: 2021-06-30 journal: Intensive Care Med DOI: 10.1007/s00134-021-06467-2 sha: c892dd583ab63ed755d65aca1504271ea8f1bea7 doc_id: 956397 cord_uid: 54258ex7 nan It was initially presumed that higher rates of delirium might be the result of direct neuronal SARS-CoV-2 infection. SARS-CoV-2 is a neurotropic virus that has the potential to enter the central nervous system (CNS) via angiotensin converting enzyme 2 (ACE2) receptors in the olfactory bulb [4] . Herpes simplex virus 1 infects the olfactory bulb and then the brain to cause encephalitis. Animal models have shown that some coronaviruses, including SARS-CoV, can do the same. However, in a single-cell RNA sequencing gene expression analysis of human biopsy samples, later confirmed in mouse models where deeper olfactory bulb tissue could be examined, ACE2 receptors were found in vascular cells (e.g., pericytes and immune cells of the macrophage/monocyte lineage) and not neurons [5] . Further, the SARS-CoV-2 virus has rarely been isolated from samples of cerebral spinal fluid (CSF), suggesting that viral replication within neurons is of less importance than other potential mechanisms such as immune-mediated damage within the CNS. Indeed, the high proportion of delirium in patients with COVID-19 associated critical illness is likely due to microvascular disease and inflammatory mechanisms. Severe coagulopathy and vascular endothelial dysfunction leading to small vessel occlusions and microhemorrhages, evident on magnetic resonance imaging, contributed to delirium rates of greater than 80% in 150 patients with COVID-19-related critical illness admitted to two centres in France [6] . In mouse models, SARS-CoV-2 infection induces a hypermetabolic state and resultant hypoxic local environment, suggesting an underlying association between viral infection and ischemic infarcts [7] . Findings of territorial ischemic lesions (n = 6; 14%), activated microglia (n = 37; 86%) and infiltration by cytotoxic T-lymphocytes (n = 34; 79%) were seen in the post-mortem evaluation of 43 patients who died with SARS-CoV-2, 12 of whom died in ICUs [8] . A distinct microbleed phenomenon in cerebral white matter has been previously described in patients with general critical illness [9] , the pathogenesis of which was attributed to hypoxemia from acute respiratory failure. Further work is needed to determine the SARS-CoV-2 dependent and independent factors or conditions responsible for microvascular and inflammatory changes seen in delirium. Delirium remains a key independent predictor of cognitive impairment and dementia incidence at least 3 months following hospitalization [10] . Certain ICUspecific delirium phenotypes (e.g., hypoxic and septic) have been associated with greater risk of long-term cognitive impairment [11] . These states may perpetuate chronic neuroinflammation and neurotoxicity [12] . Work also is underway to examine how SARSCoV2 might contribute to prolonged cognitive impairment post hospitalization. Similar neurotropic viruses such as Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS-CoV-1) coronaviruses have been shown to trigger the formation of Lewy bodies which are present in a range of neurologic diseases including Parkinson's dementia. In a post-mortem analysis of the brains of rhesus macaques infected with SARS-CoV-2 virus, in the midbrain region was infiltrated by T-lymphocytes, activated microglia and intracellular Lewy bodies [13] . Such observations might herald a higher proportion or severity of critical illness induced long-term cognitive impairment or accelerated dementia (Fig. 1) . Apart from exploring the biologic mechanisms of SARS-COV-2 related delirium, it is also crucial to consider the importance of changes to standard ICU clinical practices during COVID-19. Resources have been strained (e.g., higher nurse: patient ratios) and there has been widespread reduction in family visitations. There have been reports of deeper levels of sedation, fewer spontaneous breathing trials, and limited mobility sessions in patients with COVID-19 as compared to other critically ill patients. In a worldwide two-day prevalence study of ABCDEF bundle practices across 212 ICUs in 38 countries amidst the first wave of the pandemic, rates of adherence to individual bundle items ranged from 16% for family engagement to 62% for sedation assessment [14] . This is in comparison to pre-pandemic rates of 67% and 89%, for family engagement and sedation assessment respectively [15] . Difficulties in reaching standards of care during times of strain may contribute both to increase rate of delirium and worsened long-term sequelae. Long-term post-ICU follow-up will be instrumental to understand the full spectrum of health consequences from COVID-19-associated critical illness. Although outpatient clinics dedicated to follow-up are opening at many academic institutions, especially where large numbers of SARS-CoV-2 outbreaks have occurred, there is no standardized follow-up for survivors and their families. Creating such programs will enable standardized assessment of long-term cognitive outcomes in a representative population of critical illness survivors. Further, COVID-19 critical illness survivors potentially represent a relatively homogenous sub population with common mechanisms and offer an incredible opportunity to map out survivor biology and epidemiology, whilst generating evidence using trials to inform clinical care. MEW wrote initial draft of manuscript; DFM and MSH revised for critical content. All authors approved the final version of manuscript. Delirium and long-term cognition in critically ill patients Group C-ICIS (2021) Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 Nonneuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients Neuroinvasion of SARS-CoV-2 in human and mouse brain Neuropathology of patients with in Germany: a post-mortem case series Critical illness-associated cerebral microbleeds Association of delirium with long-term cognitive decline: a meta-analysis1 Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study Systemic infection and delirium: when cytokines and acetylcholine collide SARSCoV2 causes brain inflammation and induces Lewy body formation in macaques Common challenges to effective ABCDEF bundle implementation: the ICU liberation campaign experience Worldwide survey of the "Assessing pain, both spontaneous awakening and breathing trials, choice of drugs, delirium monitoring/management, early exercise/mobility, and family empowerment The authors have no relevant conflict of interests to declare. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.